How Toxic is the World’s Most Popular Herbicide Roundup?

Glyphosate, the active ingredient in Roundup, is designed to be toxic to plants, but scientists observe some untoward effects on animals in the lab.

Written byKatarina Zimmer
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

ISTOCK, NARONGCPGlyphosate, the active ingredient in the world’s most widely used herbicide, Roundup, is arguably also one of the most contentious. Mass protests erupted in Europe last November after the European Commission, following much discussion, granted a five-year extension for the license to use glyphosate in agriculture in the E.U.

Farmers have relied upon glyphosate-based herbicides to kill unwanted vegetation for more than four decades, but its use sparked hefty debate in 2015, when the World Health Organization’s International Agency for Research on Cancer (IARC) concluded that it was “probably carcinogenic,” adding it to a category that also contains red meat, for instance. This followed previous conclusions by research agencies such as the European Food Safety Authority (EFSA) and the U.S. Environmental Protection Agency (EPA) that glyphosate is unlikely to pose a cancer risk to humans.

There’s no question that the research around this small molecule has become highly politicized. Environmental activists have claimed that exposure is linked to everything from cancer to celiac disease to autism, while on the other hand, industry-backed reviews have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • katya katarina zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field of science and wanted to write about all of them. Following an internship with The Scientist in 2017, she’s been happily freelancing for a number of publications, covering everything from climate change to oncology. Katarina is a news correspondent for The Scientist and contributes occasional features to the magazine. Find her on Twitter @katarinazimmer and read her work on her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies